Louis Navellier
Louis Navellier (RSS)
Editor, Blue Chip Growth

Louis Navellier is one of Wall Street's renowned growth investors. Providing investment advice to tens of thousands of investors for more than three decades, he has earned a reputation as a savvy stock picker and unrivaled portfolio manager.

Read complete bio
Recent Articles

How’s the U.S. Economy? 6 Big Headlines Tell Us

Sep. 29, 2014, 1:05 pm EDT – The latest headlines suggest that investors have reasons to feel good about the U.S. economy and what's still to come. More 

Don’t Expect an Earnings Surprise From IBM

Sep. 29, 2014, 12:30 pm EDT – Between meager projections and institutional buying pressure, IBM still has a ways to go before it's a stock to buy. More 

MU: Benefit From Micron Technology’s Booming Revenue

Sep. 29, 2014, 6:00 am EDT – Investors should take advantage of Micron Technology's revenue jump and add MU stock to their portfolios for big potential returns. More 

Board Lockheed Martin Before Prices Recover

Sep. 26, 2014, 12:55 pm EDT – Given the dip from geopolitical tensions and Rosh Hashanah, Lockheed Martin is the stock to buy before it regains its cruising altitude. More 

3 Robust Stocks Worth the High Prices

Sep. 26, 2014, 9:21 am EDT – The exceptional fundamentals and exciting prospects justify the triple-digit price tags of Edwards Lifesciences, NVR and Canadian Pacific Railway. More 

Skechers: Buy SKX Stock While It Regains Its Footing

Sep. 25, 2014, 6:30 am EDT – Skechers (SKX) is still a strong stock to buy despite the concerns about sales slowing down following back-to-school season. More 

5 Great Stocks to Buy for Q4 2014

Sep. 24, 2014, 11:07 am EDT – We're most of the way through 2014. Don't let your portfolio fall apart -- pick up these 5 great stocks to buy for Q4. More 

TSLA: Tesla Stock Rally Is Running Out of Juice

Sep. 23, 2014, 3:10 pm EDT – Given its growing popularity and new factory development in Nevada, Tesla (TSLA) appears strong but could actually be stalling. More 

JNJ: Johnson & Johnson Is Still an Obvious Choice

Sep. 23, 2014, 12:05 pm EDT – Following its announcement to develop a vaccine for Ebola, Johnson & Johnson (JNJ) is a stock to buy with strong fundamentals and promising growth. More 

Don’t Shop for Amazon, Overstock or eBay

Sep. 23, 2014, 10:40 am EDT – A big IPO can create buying interest for the same sector, but the case of Alibaba, buying Amazon, Overstock or eBay would be a mistake. More